umn pharma inc
(4585:Tokyo Stock Exchange)
Manager of Clinical Research Development Department and Director,UMN Pharma Inc.
|Age||Total Calculated Compensation||This person is connected to 6 board members in 1 different organizations across 1 different industries.|
See Board Relationships
Mr. Fumihisa Nakata serves as a Manager of Clinical Research Development at UMN Pharma Inc. and has been its director since August 2010. Mr. Nakata served as Director of R&D at UMN Pharma Inc. Prior to joining UMN Pharma, Mr. Nakata was involved in vaccine development programs as a regulatory member at GlaxoSmithKline K.K. in Japan and succeeded in launching Cervarix (human papilloma virus vaccine) and various influenza vaccines. Previously, he worked in Preclinical ...
Nisso17 BuildingPhone: 81 4 5595 9840
Yokohama, Kanagawa 222-0033
Fax: 81 4 5595 9845
Board Members Memberships*
Manager of Clinical Research Development Department and Director
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.